Neurocrine Biosciences
NBIX
#1682
Rank
A$17.87 B
Marketcap
A$178.14
Share price
-1.99%
Change (1 day)
18.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company